NasdaqGM:VCYTBiotechs
Veracyte (VCYT) Turns Profitable; One-Off $27M Loss Fuels Debate on Earnings Quality
Veracyte (VCYT) has turned the corner on profitability, reporting positive earnings and a stronger net profit margin, marking an important milestone for the company. Over the last five years, earnings have grown at a rapid 29.3% per year, with analysts now forecasting another 26.6% annual earnings growth moving forward. This is well ahead of the broader US market’s outlook for profit growth. While revenue growth is expected to come in at 10.1% per year, just shy of the US average of 10.5%,...